PerpEquities

Equity · Healthcare

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) (HENGRUI) perpetual futures

HENGRUI perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade HENGRUIUSDT.

Jiangsu Hengrui Pharmaceuticals is a Chinese biopharmaceutical company that discovers, develops, manufactures and distributes medicines worldwide, with a pipeline focused on oncology, metabolic disorders, pain management and autoimmune diseases.

$7.24-0.7%
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

venue perp mark · Gate.io (HENGRUI/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$1K
Open interest
$7.6K
Best liquidity
$0
Gate.io
Tightest spread
+335.7 bps
Gate.io
Highest volume
$1K
Gate.io
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $68.2M
OI / float
0.00%
Float $23.8B
Spot performance
1D-0.72%
5D-1.87%
1M+2.88%
6M-8.71%
YTD-19.09%
1Y-22.04%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
Gate.ioTradeHENGRUI/USDTTrading$7.240.0% APR
0.000% every 8h
+335.7 bps$0$1K$7.6KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

No sufficient depth · 0 of 1 venues absorb $10k

No fresh book data: Gate.io

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

HENGRUI

Tightest spread

HENGRUI

Highest volume

HENGRUI

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-09-30 · next report 2027-04-19 · Updated 5h ago
All financials →

Valuation & key figures

Market cap
$45.8B
Updated 5h ago
Revenue
$4.9B
Trailing 12 months
Revenue growth
+7%
Next fiscal year
Profit margin
+27.0%
P/E
35.5
Peer P/E 44.6
P/S
9.3
Peer P/E
44.6
Similar listed perps
Free cash flow
$913.2M
Trailing 12 months
Net income
$1.3B
Trailing 12 months
Revenue estimate
$5B
Next fiscal year
Earnings
2027-04-19
Revenue est. $1.3B · Updated 5h ago
Dividend
¥0.2
2026-05-27
Revenue (TTM)CN¥32.9B+6.0% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)27.4%-0.3 pp vs a year agoOperating income CN¥9.01B
Net income (TTM)CN¥8.88B+18.9% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)CN¥6.11B-37.7% vs a year agoCapex CN¥3.92B
Diluted EPS (TTM)CN¥1.34+14.5% vs a year agoSum of the last 4 quarters
Net cashCN¥43.1B+6.8% vs a year agoCash + short-term investments - debt
  • Last report (2026-10-27): revenue in line, EPS beat by 11.2%Revenue CN¥8.87B vs CN¥8.91B expected (-0.4%); EPS CN¥0.37 vs CN¥0.33 (+11.2%).
  • Revenue growth accelerating: 20.6% year on yearQ3 '26 revenue CN¥8.95B, against an average of 4.9% over the four quarters before.
  • Operating margin 27.4% (TTM), -0.3 pp on a year agoOperating income grew 4.9% while revenue grew 6.0%.
  • 10.1% of pre-tax profit is non-operatingPre-tax income CN¥10B vs operating income CN¥9.01B (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.

Revenue, operating income and growth

quarterly
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates

Next catalyst

Catalysts

Earnings
2027-04-19
Revenue est. $1.3B · Updated 5h ago
Dividend
¥0.2
2026-05-27

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20260.21$5B+7%12
FY 20270.23$5.7B+21%10
FY 20280.27$6.5B+38%14
FY 20290.43$8.9B+90%7
FY 20300.54$11B+135%11
Q3 20260.05$1.3B+20%2

Company events

6
2027-04-19EarningsActual - / Estimate 0.32-
2026-10-27EarningsActual 0.37 / Estimate 0.33Beat
2026-08-19EarningsActual 0.33 / Estimate 0.41Miss
2026-05-27Dividend¥0.2-
2026-04-22EarningsActual 0.34 / Estimate 0.33Beat
2026-03-25EarningsActual 0.31 / Estimate 0.34Miss

Peer comparison

Similar listed perps

Company data

Company intelligence

Updated: Nov 2, 2026, 04:44 PM UTC

Company profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chief executive
Sun Piaoyang
Employees
20,602
IPO date
Oct 18, 2000
Country
CN
Exchange
Shanghai Stock Exchange
Website
Altman Z-scorei22.38
Piotroski scorei7/9
Overall ratingiA-
Owner earningsiCN¥5.15BCN¥0.78 per share

Rating factors

Return on equityi
4
Return on assetsi
5
Debt to equityi
4
Price to earningsi
2
Price to booki
2
Market cap history
CN¥321.38B-8.1%Aug 26 – Nov 26
CN¥284.81BCN¥321.15BCN¥357.48BHigh: CN¥357.48B · 2026-08-10Low: CN¥284.81B · 2026-09-14Latest: CN¥321.38B · 2026-11-02Aug 26Sep 26Oct 26Nov 26
Latest: CN¥321.38B · 2026-11-02High: CN¥357.48B · 2026-08-10Low: CN¥284.81B · 2026-09-14
Largest fund holders
FundWeightShares held
VXUS0.01%6.1M
VWO0.02%6M
IEMG0.02%4.4M
2823.HK1.7%3.8M
CNYA.LN.L0.85%2.8M
AMEG.L0.58%2.4M
ISFF401.TA0.64%2.2M
82822.HK1.7%1.8M
ASHR0.97%1.7M
EIMI.L0.02%1.2M
EIMU DE0.02%1.2M
TWMIX0.45%1.2M

Analyst track record

How the analysts covering HENGRUI have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings00
Analysts00
Buy / hold / sell––
Upgrades / downgrades / initiations0 / 0 / 00 / 0 / 0
Price targets hit / missed––
Avg. return after a rating (TipRanks)––
Best / worst call– / –– / –

After buy calls on this stock: not enough measured cases yet

TipRanks data · computed Nov 5, 2026 · 0 ratings

Frequently asked questions

Where can I trade HENGRUI perpetual futures?

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) (HENGRUI) perpetual futures trade on 1 crypto venues, including Gate.io. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade HENGRUI around the clock?

Yes. Unlike the underlying stock, HENGRUI perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on HENGRUI perpetuals?

Right now the HENGRUI perp funding rate is 0.0% annualized (venue median), ranging from 0.0% to 0.0% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the HENGRUI perp price compare to the Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) stock?

The venue-median HENGRUI perp mark is $7.24 versus a reference stock price of $7.24, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a HENGRUI perpetual future?

A HENGRUI perpetual is a derivative that tracks the price of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) with no expiry date. It lets you take long or short exposure to Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) on crypto venues, around the clock.

What is HENGRUIUSDT perpetual?

HENGRUIUSDT is the symbol most crypto exchanges use for the Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) perpetual settled in USDT (Tether). It tracks the HENGRUI share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

HENGRUI perpetuals · perpequities.comHENGRUI perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/hengrui-perp"><img src="https://perpequities.com/badge/hengrui-perp.svg" width="240" height="64" alt="HENGRUI perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of HENGRUI perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for HENGRUI — one email every Sunday.

Watchlist and alerts

Price and funding alerts for HENGRUI, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X